Can Maternal Autoantibodies Play an Etiological Role in ASD Development?

Iva Dudova,1 Klara Horackova,2 Michal Hrdlicka,1 Martin Balastik3 1Department of Child Psychiatry, Charles University Second Faculty of Medicine, Prague, Czech Republic; 2Department of Psychiatry, Charles University First Faculty of Medicine, Prague, Czech Republic; 3Laboratory of Molecular Neurobio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dudova I, Horackova K, Hrdlicka M, Balastik M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	maternal autoantibodies autism spectrum disorder animal models crmp2 therapy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a9432f6d636f402292f65f7c5253fa28
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a9432f6d636f402292f65f7c5253fa28
record_format	dspace
spelling	oai:doaj.org-article:a9432f6d636f402292f65f7c5253fa282021-12-02T12:01:50ZCan Maternal Autoantibodies Play an Etiological Role in ASD Development?1178-2021https://doaj.org/article/a9432f6d636f402292f65f7c5253fa282020-06-01T00:00:00Zhttps://www.dovepress.com/can-maternal-autoantibodies-play-an-etiological-role-in-asd-developmen-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Iva Dudova,1 Klara Horackova,2 Michal Hrdlicka,1 Martin Balastik3 1Department of Child Psychiatry, Charles University Second Faculty of Medicine, Prague, Czech Republic; 2Department of Psychiatry, Charles University First Faculty of Medicine, Prague, Czech Republic; 3Laboratory of Molecular Neurobiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech RepublicCorrespondence: Iva DudovaDepartment of Child Psychiatry, Charles University Second Faculty of Medicine, University Hospital Motol, V Uvalu 84, Prague 15006, Czech RepublicTel +420 224 433 458Fax +420 224 433 420Email iva.dudova@lfmotol.cuni.czAbstract: Autism spectrum disorder (ASD) is a heterogeneous condition with multiple etiologies and risk factors – both genetic and environmental. Recent data demonstrate that the immune system plays an important role in prenatal brain development. Deregulation of the immune system during embryonic development can lead to neurodevelopmental changes resulting in ASD. One of the potential etiologic factors in the development of ASD has been identified as the presence of maternal autoantibodies targeting fetal brain proteins. The type of ASD associated with the presence of maternal autoantibodies has been referred to as maternal antibodies related to ASD (MAR ASD). The link between maternal autoantibodies and ASD has been demonstrated in both clinical studies and animal models, but the exact mechanism of their action in the pathogenesis of ASD has not been clarified yet. Several protein targets of ASD-related maternal autoantibodies have been identified. Here, we discuss the role of microtubule-associated proteins of the collapsin response mediator protein (CRMP) family in neurodevelopment and ASD. CRMPs have been shown to integrate multiple signaling cascades regulating neuron growth, guidance or migration. Their targeting by maternal autoantibodies could change CRMP levels or distribution in the developing nervous system, leading to defects in axon growth/guidance, cortical migration, or dendritic projection, which could play an etiological role in ASD development. In addition, we discuss the future possibilities of MAR ASD treatment.Keywords: maternal autoantibodies, autism spectrum disorder, animal models, CRMP2, therapyDudova IHorackova KHrdlicka MBalastik MDove Medical Pressarticlematernal autoantibodiesautism spectrum disorderanimal modelscrmp2therapyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1391-1398 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	maternal autoantibodies autism spectrum disorder animal models crmp2 therapy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	maternal autoantibodies autism spectrum disorder animal models crmp2 therapy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Dudova I Horackova K Hrdlicka M Balastik M Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
description	Iva Dudova,1 Klara Horackova,2 Michal Hrdlicka,1 Martin Balastik3 1Department of Child Psychiatry, Charles University Second Faculty of Medicine, Prague, Czech Republic; 2Department of Psychiatry, Charles University First Faculty of Medicine, Prague, Czech Republic; 3Laboratory of Molecular Neurobiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech RepublicCorrespondence: Iva DudovaDepartment of Child Psychiatry, Charles University Second Faculty of Medicine, University Hospital Motol, V Uvalu 84, Prague 15006, Czech RepublicTel +420 224 433 458Fax +420 224 433 420Email iva.dudova@lfmotol.cuni.czAbstract: Autism spectrum disorder (ASD) is a heterogeneous condition with multiple etiologies and risk factors – both genetic and environmental. Recent data demonstrate that the immune system plays an important role in prenatal brain development. Deregulation of the immune system during embryonic development can lead to neurodevelopmental changes resulting in ASD. One of the potential etiologic factors in the development of ASD has been identified as the presence of maternal autoantibodies targeting fetal brain proteins. The type of ASD associated with the presence of maternal autoantibodies has been referred to as maternal antibodies related to ASD (MAR ASD). The link between maternal autoantibodies and ASD has been demonstrated in both clinical studies and animal models, but the exact mechanism of their action in the pathogenesis of ASD has not been clarified yet. Several protein targets of ASD-related maternal autoantibodies have been identified. Here, we discuss the role of microtubule-associated proteins of the collapsin response mediator protein (CRMP) family in neurodevelopment and ASD. CRMPs have been shown to integrate multiple signaling cascades regulating neuron growth, guidance or migration. Their targeting by maternal autoantibodies could change CRMP levels or distribution in the developing nervous system, leading to defects in axon growth/guidance, cortical migration, or dendritic projection, which could play an etiological role in ASD development. In addition, we discuss the future possibilities of MAR ASD treatment.Keywords: maternal autoantibodies, autism spectrum disorder, animal models, CRMP2, therapy
format	article
author	Dudova I Horackova K Hrdlicka M Balastik M
author_facet	Dudova I Horackova K Hrdlicka M Balastik M
author_sort	Dudova I
title	Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
title_short	Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
title_full	Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
title_fullStr	Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
title_full_unstemmed	Can Maternal Autoantibodies Play an Etiological Role in ASD Development?
title_sort	can maternal autoantibodies play an etiological role in asd development?
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/a9432f6d636f402292f65f7c5253fa28
work_keys_str_mv	AT dudovai canmaternalautoantibodiesplayanetiologicalroleinasddevelopment AT horackovak canmaternalautoantibodiesplayanetiologicalroleinasddevelopment AT hrdlickam canmaternalautoantibodiesplayanetiologicalroleinasddevelopment AT balastikm canmaternalautoantibodiesplayanetiologicalroleinasddevelopment
_version_	1718394767761473536

Can Maternal Autoantibodies Play an Etiological Role in ASD Development?

Ejemplares similares